Publication Author: Urban_Nicole

• Developing measures of mammography performance.

  Urban N. Developing measures of mammography performance. Med Care. 2002 Jun;40(6 Suppl):III86-8.

  rakerr2

  June 1, 2002

• Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer.

  Andersen MR, Peacock S, Nelson J, Wilson S, McIntosh M, Drescher C, Urban N. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol. 2002 Apr;85(1):3-8.

  rakerr2

  April 1, 2002

• Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography.

  Taplin SH, Ichikawa LE, Kerlikowske K, Ernster VL, Rosenberg RD, Yankaskas BC, Carney PA, Geller BM, Urban N, Dignan MB, Barlow WE, Ballard-Barbash R, Sickles EA. Concordance of breast imaging reporting and data system assessments and management recommend

  rakerr2

  February 1, 2002

• Generating longitudinal screening algorithms using novel biomarkers for disease.

  McIntosh MW, Urban N, Karlan B. Generating longitudinal screening algorithms using novel biomarkers for disease. Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):159-66.

  rakerr2

  February 1, 2002

• Information women receive about heart attacks and how it affects their knowledge, beliefs, and intentions to act in a cardiac emergency.

  Meischke H, Kuniyuki A, Yasui Y, Bowen DJ, Andersen R, Urban N. Information women receive about heart attacks and how it affects their knowledge, beliefs, and intentions to act in a cardiac emergency. Health Care Women Int. 2002 Feb;23(2):149-62.

  rakerr2

  February 1, 2002

• Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

  Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

  rakerr2

  October 16, 2001

• MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily.

  Stone B, Schummer M, Paley PJ, Crawford M, Ford M, Urban N, Nelson BH. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene. 2001 Apr 18;267(2):173-82.

  rakerr2

  April 18, 2001

• Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes.

  McIntosh M, Ramsey S, Berry K, Urban N. Parameter solicitation for planning cost effectiveness studies with dichotomous outcomes. Health Econ. 2001 Jan;10(1):53-66. Review.

  rakerr2

  January 1, 2001

• Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening.

  Crump C, McIntosh MW, Urban N, Anderson G, Karlan BY. Ovarian cancer tumor marker behavior in asymptomatic healthy women: implications for screening. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1107-11.

  rakerr2

  October 1, 2000

• Simulation modeling of outcomes and cost effectiveness.

  Ramsey SD, McIntosh M, Etzioni R, Urban N. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am. 2000 Aug;14(4):925-38. Review.

  rakerr2

  August 1, 2000